Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans

<div>HCI assay examples for assessment of specific cellular functions and toxicity. For more details, please refer to Uteng et al. [<a href="/journals/bmri/2016/9737920/#B156">81</a>]. Figure reproduced with permission.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans 

Figure 3 | Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans 